课题基金 / 基金详情

Chemical biology study on protein phosphatases and their specific inhibitors.

Chemical biology study on protein phosphatases and their specific inhibitors.
蛋白磷酸酶及其特异性抑制剂的化学生物学研究。
批准号:
12045268
负责人:
OSADA Hiroyuki
金额:
$12.67万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

OSADA Hiroyuki的其他基金

相似基金

相关文献

中文摘要
翻译
参与信号转导的蛋白质在增殖、分化和凋亡的过程中受到磷酸化/去磷酸化的调节。许多选择性的蛋白激酶抑制剂已经被开发出来,但是选择性的磷酸酶抑制剂的开发还没有实现。为了解决这个问题,我试图开发磷酸酶抑制剂。1.4-异伐那西汀被分离作为VHR蛋白酪氨酸磷酸酶的抑制剂。由于4-异燕麦内酯具有一个反应性的外亚甲基部分,因此4-异燕麦内酯可能通过直接修饰催化位点的半胱氨酸残基来抑制VHR。由于双特异性磷酸酶在催化位点具有一个共有的CXXXXXR基序,因此双特异性磷酸酶对4-异燕麦内酯敏感。是丝氨酸苏氨酸磷酸酶的有效和选择性抑制剂,PP 2A.用稳定同位素标记环己烷羧酸(CHC)的掺入研究表明,由链霉菌HK-803产生的六种PLM类似物(PLM A-F)都是从CHC起始单元生物合成的。对该菌株75 kb的PLM生物合成基因簇进行了克隆、测序和分析,该基因簇包含6个基因(plml-7),它们分别包含PLM聚酮合酶I型模块的装载结构域和7个延伸模块。
英文摘要
Proteins involved in the signal transduction are regulated by phosphorylation/dephosphorylation during a process of proliferation, differentiation and apoptosis.Many selective inhibitors for protein kinases have been developed, however development of selective phosphatase inhibitors has not been achieved yet.To resolve this problem, I have tried to develop phosphatase inhibitors.1.4-isovavenaciolide was isolated as an inhibitor of the VHR protein tyrosine phosphatase. As 4-isoavenaciolide possesses a reactive exo-methylene moiety, it is possible that 4-isoavenaciolide inhibits VHR through the direct modification of a cysteine residue in the catalytic site.Since dual-specificity phosphatases have a consensus CXXXXXR motif in the catalytic site, dual-specificity phosphatases are sensitive to 4-isoavenaciolide.2.Phoslactomycins (PLMs) produced by Streptomyces, are potent and selective inhibitors of serine threonine phosphatases, PP2A.Incorporation studies with stable isotope labeling cyclohexanecarboxylic acid (CHC) indicated that the six PLM analoges (PLM A-F) made by Streptomyces sp.HK-803 are all biosynthesized from a CHC starter unit.Hydroxylation of the CHC-derived side chain of PLM B and a subsequent esterification produces the remaining PLM analogs.The entire 75 kb PLM biosynthetic gene cluster of the producing strain was cloned, sequenced and analyzed.Thecluster contains six genes (plml-7) which comprise the loading domain and seven extension modules of the type I modular PLM polyketide synthase.
期刊论文(373)
专著(0)
科研奖励(0)
会议论文
Takanami-Ohnishi, Y. et al.: "Essential role of p38 mitogen-activated protein kinase in contact hypersensitivity."J.Biol.Chem.. 277. 37896-37903 (2002)
Takanami-Ohnishi, Y. 等人:“p38 丝裂原激活蛋白激酶在接触性超敏反应中的重要作用。”J.Biol.Chem.. 277. 37896-37903 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Cui, C.-B.et al.: "A new polyphenolic compound from Rubus aleaefolius and its inhibitory activity on mammalian cell cycle at GO/G1 phase."Chinese Chem.Lett.. 13. 327-330 (2002)
Cui, C.-B.et al.:“一种来自悬钩子的新多酚化合物及其对 GO/G1 期哺乳动物细胞周期的抑制活性。”Chinese Chem.Lett.. 13. 327-330 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Osada, H.: "An overview on the diversity of actinomycete metabolites."Actinomycetol.. 15. 11-14 (2001)
Osada, H.:“放线菌代谢物多样性概述。”Actinomycetol.. 15. 11-14 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shoji, M., Kishida, S., Takeda, M., Kakeya, H., Osada, H., Hayashi, Y.: "A practical total synthesis of both enantiomers of epoxyquinols A and B."Tetrahedron Lett.. 43. 9155-1958 (2002)
Shoji, M.、Kishida, S.、Takeda, M.、Kakeya, H.、Osada, H.、Hayashi, Y.:“环氧醌醇 A 和 B 两种对映体的实用全合成。”Tetrahedron Lett.. 43
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 184 条
    Construction of the database of microbial products and its application study
    Chemical proteomics to reveal interaction between chemicals and proteins at angstrom level
    Drug discovery research based on the molecular mechanisms of tumor growth and metastasis
    Development of small-molecular-bioprobes and proteomic analyses of signal transduction factors.
    • 批准号:
      15310156
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2003
    • 负责人:
      OSADA Hiroyuki
    • 依托单位:
    国内基金
    海外基金
    蛋白磷酸酶1调节亚基3c(PPP1R3c)调控肝脏糖异生的作用及机制研究
    • 批准号:
      82370810
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      陆洁莉
    • 依托单位:
    酪氨酸磷酸酶SHP1新型作用底物THEMIS的鉴定及其在免疫T细胞发育过程中的功能探究
    • 批准号:
      32070776
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      范高峰
    • 依托单位: